Comprised of the cardiologist and the heart surgeon, the heart team collaboratively assesses and determines the best course of treatment for cardiac patients. ECHI has a large and successful surgical and percutaneous valve program built on the heart team concept. This approach is also used for treating patients with coronary artery disease by applying the use of fractional flow reserve (FFR). 



A report released by IMV Medical Information Division found that providers of nuclear medicine (NM) services are consolidating as procedure volume dropped in the subspecialty from 2008 to 2012. 


The National Institutes of Health announced that a network of 25 regional stroke centers working with nearby satellite facilities will span the country, have teams of researchers representing every medical specialty needed for stroke care and will address the three prongs of stroke research: prevention, treatment and recovery.

AtriCure Inc., an atrial fibrillation (AF) medical device provider, and Endoscopic Technologies Inc, doing business as “Estech,” announced that they have entered into a definitive merger agreement under which AtriCure has agreed to acquire Estech.


A study shows that coronary artery calcium (CAC) screening, an assessment tool that is not currently recommended for people considered at low risk, should play a more prominent role in helping determine a person’s risk for heart attack and heart disease-related death, as well as the need for angioplasty or bypass surgery.



Clinical trials for a promising new class of cholesterol-lowering medications, a long-awaited repair of the Medicare formula for paying physicians, the Affordable Care Act, new technology and the implementation of new prevention guidelines are among the top developments in cardiology anticipated for 2014.



It was not until we began planning that we realized just how involved TAVR programs are — they require much more work than we originally anticipated. At Terrebonne General Medical Center (TGMC), our TAVR program started as part of a research project in our structural heart department. It was an opportunity to offer advanced patient care and determine the effectiveness of TAVR on patients experiencing severe aortic stenosis, who were deemed inoperable by two cardiac surgeons.

Subscribe Now